moxifloxacin has been researched along with bms 214662 in 1 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (bms 214662) | Trials (bms 214662) | Recent Studies (post-2010) (bms 214662) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 49 | 8 | 9 |
Protein | Taxonomy | moxifloxacin (IC50) | bms 214662 (IC50) |
---|---|---|---|
GTPase HRas | Homo sapiens (human) | 0.0013 | |
GTPase KRas | Homo sapiens (human) | 0.7723 | |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.3617 | |
Protein farnesyltransferase subunit beta | Homo sapiens (human) | 0.0021 | |
Geranylgeranyl transferase type-1 subunit beta | Homo sapiens (human) | 1.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for moxifloxacin and bms 214662
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |